Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyFulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
7d ago
Fulcrum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Fulcrum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
7d ago
Leerink gives Fulcrum fourth downgrade after study failure
Premium
The Fly
Leerink gives Fulcrum fourth downgrade after study failure
7d ago
Fulcrum Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyFulcrum Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
8d ago
Fulcrum Therapeutics suspends future losmapimod development after Phase 3 trial
Premium
The Fly
Fulcrum Therapeutics suspends future losmapimod development after Phase 3 trial
8d ago
Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
Premium
Press Releases
Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
8d ago
Fulcrum Therapeutics to Participate in Upcoming September Conferences
PremiumPress ReleasesFulcrum Therapeutics to Participate in Upcoming September Conferences
23d ago
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
27d ago
Fulcrum appoints Isabel Kalofonos as CCO
Premium
The Fly
Fulcrum appoints Isabel Kalofonos as CCO
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100